日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial

Evolocumab 可降低无已知显著动脉粥样硬化且患有糖尿病的患者首次发生重大心血管事件的风险:VESALIUS-CV 试验结果

Marston, Nicholas A; Bohula, Erin A; Bhatia, Ajay K; De Ferrari, Gaetano M; Leiter, Lawrence A; Nicolau, Jose C; Park, Jeong-Gun; Murphy, Sabina A; Walsh, Emileigh; Liu, Lyrica; Verma, Subodh; Sattar, Naveed; Nicholls, Stephen J; Lopez-Sendon, Jose; Gouni-Berthold, Ioanna; Tokgozoglu, Lale; Blankstein, Ron; Cyrille, Marcoli; da Silva Lima, Gabriel Paiva; Giugliano, Robert P; Sabatine, Marc S

Coronary atherosclerotic plaque intervention with Tongxinluo capsule (TXL-CAP): a multicenter, randomized, double-blind and placebo-controlled study

通心络胶囊(TXL-CAP)治疗冠状动脉粥样硬化斑块:一项多中心、随机、双盲、安慰剂对照研究

Ni, Mei; Ti, Yun; Yu, Huai; Zhang, Meng; Qi, Yan; Duan, Dayue Darrel; Xie, Qiang; Ji, Zheng; Zhao, Ranzun; Zhou, Yujie; Chen, Shaoliang; Wang, Lin; Zhang, Yaojun; Guo, Jincheng; He, Yuquan; Yao, Chen; Bu, Peili; Yu, Bo; Zhang, Yun; Zhang, Cheng

Nature-inspired confined cascade enzyme nanoreactors for targeted atherosclerosis therapy

受自然启发的受限级联酶纳米反应器用于靶向动脉粥样硬化治疗

Yuehuang Wu #,Hongping Xia #,He Ding,Mengmeng Long,Sen Yan,Miao Zhang,Jingyi Sheng,Ning Gu

HELZ2 Regulates Apob mRNA Stability to Modulate Fatty Liver Disease and Atherosclerosis.

HELZ2 调节 Apob mRNA 稳定性以调节脂肪肝疾病和动脉粥样硬化。

Limitations of current animal models in atherosclerosis: an integrative multiomics perspective

当前动脉粥样硬化动物模型的局限性:一种整合多组学视角

Kardassis, Dimitris; Amigó, Núria; Mitić, Tijana

Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression

通过巨噬细胞仿生纳米颗粒协同增强胞吞作用和胆固醇外流,从而减缓动脉粥样硬化的进展。

Cai, Shiteng; Gao, Jinfeng; Weng, Xueyi; Wang, Zhengmin; Zheng, Danwen; Wang, Qiaozi; Li, Qiyu; Han, Chengzhi; Li, Weiyan; Chen, Jing; Fu, Yuyuan; Tan, Yiwen; Wei, Bohan; Pang, Zhiqing; Huang, Zheyong; Song, Yanan; Ge, Junbo

Advancements in dual-targeting nanoparticle strategies for enhanced atherosclerosis therapy: Overcoming limitations of single-targeting approaches

双靶向纳米颗粒策略在增强动脉粥样硬化治疗中的应用进展:克服单靶向方法的局限性

Yang, Can; Mo, Liqing; Zhang, Guizhi; Dai, Yingxuan; Li, Binxiang; Tan, Zihan; Guo, Yujie; Lu, Shan; Hong, Yi; He, Hongliang; Yang, Hu; He, Jianhua

Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy.

通过黄芩苷-铜网络无载体口服共递送阿托伐他汀,以逆转衰老和多机制协同作用治疗动脉粥样硬化。

Liu Kaijing, Li Gen, Liang Xiaoyu, Wang Changduo, Zhu Ni, Fu Xue, Zhang Yujie, Liu Chao, Yang Jing

A foam cell-targeted lipophagy restoration strategy stabilizes vulnerable atherosclerotic plaques.

以泡沫细胞为靶点的脂质自噬修复策略可稳定易损的动脉粥样硬化斑块。

Li Heng, Qin Yusheng, Zhang Jianhong, Guo Xinlin, Hu Xiaolin, Sun Danlei, Zhao Yue, Bernardini Sergio, Xu Daqian, Jiang Peng, Zhang Hong, Luo Yang

Active commuting and atherosclerosis in a population-based sample of middle-aged adults: the Swedish CArdioPulmonary bioImage study (SCAPIS)

瑞典心肺生物影像研究(SCAPIS):中年人群样本中积极通勤与动脉粥样硬化的关系

Edholm, Peter; Wennberg, Patrik; Ballin, Marcel; Östgren, Carl-Johan; Daka, Bledar; Berglind, Daniel; Lenander, Cecilia; Ahlqvist, Viktor H; Rådholm, Karin; Henriksson, Pontus; Herraiz-Adillo, Ángel